Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
5,730.00
0.00 (0.00%)
Last updated: Sep 19, 2025, 12:07 PM KST
Sinsin Pharmaceutical Revenue
Sinsin Pharmaceutical had revenue of 29.60B KRW in the quarter ending June 30, 2025, with 0.47% growth. This brings the company's revenue in the last twelve months to 107.13B, up 1.79% year-over-year. In the year 2024, Sinsin Pharmaceutical had annual revenue of 106.39B with 3.71% growth.
Revenue (ttm)
107.13B
Revenue Growth
+1.79%
P/S Ratio
0.81
Revenue / Employee
300.92M
Employees
356
Market Cap
86.78B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 106.39B | 3.80B | 3.71% |
Dec 31, 2023 | 102.59B | 10.66B | 11.60% |
Dec 31, 2022 | 91.93B | 17.92B | 24.21% |
Dec 31, 2021 | 74.01B | 6.88B | 10.25% |
Dec 31, 2020 | 67.13B | -725.72M | -1.07% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hanwha Aerospace | 19.25T |
Hyundai Motor Company | 182.25T |
HD Hyundai Heavy Industries | 15.58T |
KB Financial Group | 14.92T |